20.11.2017 23:41:00

Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

NEW YORK, Nov. 20, 2017 /PRNewswire/ -- Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Read the full report: https://www.reportlinker.com/p05206714

Summary
GlobalData's new report, Japan In Vitro Diagnostics (IVD) Market Outlook to 2024, provides key market data on the Japan In Vitro Diagnostics (IVD) market. The report provides value, in millions of US dollars and volume (in units) within market categories - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
- Market size and company share data for In Vitro Diagnostics (IVD) market categories - - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics, Microbiology Culture.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Japan In Vitro Diagnostics (IVD) market.
- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Sysmex Corp, Siemens Healthcare GmbH, Beckman Coulter Inc, Thermo Fisher Scientific Inc and Others.

Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Read the full report: https://www.reportlinker.com/p05206714

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

View original content:http://www.prnewswire.com/news-releases/japan-in-vitro-diagnostics-ivd-market-outlook-to-2024---clinical-chemistry-genetic-testing-hematology-histology-and-cytology-immuno-chemistry-infectious-diagnostics-and-microbiology-culture-300559774.html

SOURCE Reportlinker

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!